Pharmaceutical Research and Manufacturers of America
- World rank, all time
- #27,362 of 42,892
- Rank in United States
- #5,870 of 8,685
- Research works
- 185 ▼ 33% vs 2013–17
- Citations
- 2.3k 12.5 per fractional work
- Top-10% rate
- 10.3% record average 16.5%
- Open access
- 21% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 27.7×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 27.7×
- Economics, Econometrics and Finance 13.1×
- Chemistry 2.9×
- Biochemistry, Genetics and Molecular Biology 2.0×
- Immunology and Microbiology 1.9×
- Mathematics 1.6×
- Medicine 1.3×
- Nursing 1.1×
- Computer Science 1.0×
- Social Sciences 0.6×
- Materials Science 0.3×
- Health Professions 0.1×
- Engineering 0.1×
Which keywords describe research at Pharmaceutical Research and Manufacturers of America?
By fractional works in all years, weighted toward what it does more of than the world: Pharmaceutical Industry, Market Size, Drug Development Costs, Generic Drugs, Clinical Trials, Publication Bias, Conflict of Interest and Research Outcome.
- Patient Compliance
- Biopharmaceuticals
- Monoclonal Antibodies
- Health Outcomes
- Regulatory Challenges
- Polypharmacy
- Inappropriate Medication Use
- Ethical Considerations
- Drug Development
- Global Governance
- Medication Adherence
- Health Biotechnology
- Entrepreneurship
- Developing Countries
- Health Utility Measures
- Quality of Life
- Research Outcome
- Publication Bias
- Generic Drugs
- Market Size
- Pharmaceutical Industry
- Drug Development Costs
- Clinical Trials
- Conflict of Interest
- Innovation
- Cost-effectiveness Analysis
- Intellectual Property
- Emerging Markets
- Global Collaboration
- Primary Care
- Chronic Disease Management
- Patient Safety
- Elderly
- Health Care Spending
- Insurance Markets
- Healthcare
- Stem Cell Regulation
- Adverse Drug Reactions
- Cardiovascular Disease Prevention
- Immunogenicity
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Pharmaceutical Industry44▲ 590×2 topics
- Market Size30▲ 210×2 topics
- Drug Development Costs30▲ 637×1 topic
- Generic Drugs30▲ 637×1 topic
- Clinical Trials25▲ 21×7 topics
- Publication Bias16▲ 164×3 topics
- Conflict of Interest14▲ 571×1 topic
- Research Outcome14▲ 571×1 topic
- Innovation13▲ 7.9×7 topics
- Quality of Life11▲ 4.6×4 topics
- Cost-effectiveness Analysis11▲ 75×1 topic
- Health Utility Measures11▲ 75×1 topic
- Intellectual Property8▲ 45×3 topics
- Developing Countries8▲ 65×2 topics
- Emerging Markets8▲ 86×2 topics
- Entrepreneurship8▲ 16×2 topics
- Global Collaboration8▲ 102×1 topic
- Health Biotechnology8▲ 221×1 topic
- Primary Care8▲ 10×5 topics
- Medication Adherence7▲ 62×2 topics
- Chronic Disease Management6▲ 22×3 topics
- Global Governance6▲ 14×4 topics
- Patient Safety6▲ 27×2 topics
- Drug Development6▲ 22×2 topics
- Elderly5▲ 12×2 topics
- Ethical Considerations5▲ 8.8×7 topics
- Health Care Spending5▲ 44×1 topic
- Inappropriate Medication Use5▲ 71×1 topic
- Insurance Markets5▲ 44×1 topic
- Polypharmacy5▲ 71×1 topic
- Healthcare5▲ 3.9×8 topics
- Regulatory Challenges5▲ 34×1 topic
- Stem Cell Regulation5▲ 115×1 topic
- Health Outcomes5▲ 11×3 topics
- Adverse Drug Reactions4▲ 36×3 topics
- Monoclonal Antibodies4▲ 16×3 topics
- Cardiovascular Disease Prevention4▲ 28×2 topics
- Biopharmaceuticals4▲ 31×2 topics
- Immunogenicity4▲ 41×2 topics
- Patient Compliance4▲ 94×1 topic
Which research topics does Pharmaceutical Research and Manufacturers of America publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Economic and Financial Impacts of Cancer and Medication Adherence and Compliance.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
- 3 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 4 Medication Adherence and Compliance Family Practice 0 works
- 5 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
- 6 Artificial Intelligence in Healthcare and Education Health Informatics 0 works
- 7 Protein purification and stability Molecular Biology 0 works
- 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 9 Vaccine Coverage and Hesitancy Health 0 works
- 10 Machine Learning in Healthcare Artificial Intelligence 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pharmaceutical Research and Manufacturers of America's research output changed?
Output in 2018–2022 was 33% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Washington
- Georgetown University
- George Washington University
- United States Naval Research Laboratory
- Agricultural Research Service
- United States Department of Veterans Affairs
- United States Department of Agriculture
- American University
- Environmental Protection Agency
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.